Phathom Pharmaceuticals Inc (OQ:PHAT)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for PHAT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Yamada Tadataka Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 10,000  
May 22/20 May 21/20 Topper James N Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 10,000  
May 22/20 May 21/20 Fields Heidi Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 10,000  
May 22/20 May 21/20 Cola Michael F Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 10,000  
Apr 3/20 Apr 1/20 Ra Capital Management, L.P. Indirect Ownership Common Stock P - Open market or private purchase 117,600 $24.86
Mar 31/20 Mar 31/20 Ra Capital Management, L.P. Indirect Ownership Common Stock P - Open market or private purchase 30,600 $24.55
Mar 31/20 Mar 27/20 Ra Capital Management, L.P. Indirect Ownership Common Stock P - Open market or private purchase 30,000 $24.60
Mar 19/20 Mar 17/20 Stenhouse Mark Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Feb 6/20 Feb 6/20 Ra Capital Management, L.P. Indirect Ownership Common Stock Form 3/A : Amendment of a previous Form 3    
Nov 4/19 Nov 4/19 Ra Capital Management, L.P. Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for PHAT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Yamada Tadataka Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 10,000  
May 22/20 May 21/20 Topper James N Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 10,000  
May 22/20 May 21/20 Fields Heidi Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 10,000  
May 22/20 May 21/20 Cola Michael F Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 10,000  
Apr 3/20 Apr 1/20 Ra Capital Management, L.P. Indirect Ownership Common Stock P - Open market or private purchase 117,600 $24.86
Mar 31/20 Mar 31/20 Ra Capital Management, L.P. Indirect Ownership Common Stock P - Open market or private purchase 30,600 $24.55
Mar 31/20 Mar 27/20 Ra Capital Management, L.P. Indirect Ownership Common Stock P - Open market or private purchase 30,000 $24.60
Mar 19/20 Mar 17/20 Stenhouse Mark Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Feb 6/20 Feb 6/20 Ra Capital Management, L.P. Indirect Ownership Common Stock Form 3/A : Amendment of a previous Form 3    
Nov 4/19 Nov 4/19 Ra Capital Management, L.P. Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $PHAT

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)